Net Deals Web Search

Search results

1. Results From The WOW.Com Content Network

2. A Full List of Recalled Eye Drops Linked to Potential ... - AOL

   www.aol.com/full-list-recalled-eye-drops...

   Clear Eyes Once Daily, Eye Allergy Itch Relief: Not officially linked to any bacterial infection cases being traced by the CDC, the FDA has indicated this brand's manufacturer, Teva ...

3. Over 27 Eye Drops Have Been Recalled: What You Need to Know - AOL

   www.aol.com/lifestyle/eye-drop-recall-know...

   [table-of-contents] stripped. It’s been a bad year for eye drops. The U.S. Food and Drug Administration (FDA) has issued yet another eye drop recall—this time focusing on 27 different over-the ...

4. Is it safe to use eyedrops? What to know about the FDA ... - AOL

   www.aol.com/news/safe-eyedrops-know-fda-warnings...

   The Food and Drug Administration recently cautioned consumers against using 27 different kinds of eyedrops — its third eyedrop-related warning this year — leading Americans to question whether ...

5. Olopatadine - Wikipedia

   en.wikipedia.org/wiki/Olopatadine

   Olopatadine is an active ingredient in eye drops designed to alleviate allergic conjunctivitis, a condition characterized by itchy, red, and watery eyes. It is intended to serve as a superior alternative to eye drops that contain corticosteroids. By utilizing olopatadine, the goal is to minimize the side effects associated with corticosteroids.

6. Naphazoline - Wikipedia

   en.wikipedia.org/wiki/Naphazoline

   Naphazoline is a medicine used as a decongestant, and a vasoconstrictor added to eye drops to relieve red eye. It has a rapid action in reducing swelling when applied to mucous membranes . It is a sympathomimetic agent with marked alpha adrenergic activity that acts on alpha-receptors in the arterioles of the conjunctiva to produce constriction ...

7. 2022–2023 United States P. aeruginosa outbreak in eye drops

   en.wikipedia.org/wiki/2022–2023_United_States_P...

   The 2022–2023 United States Pseudomonas aeruginosa outbreak began in May 2022, with the infection of several patients in California. The Centers for Disease Control and Prevention (CDC) became aware of a strain of Pseudomonas aeruginosa in artificial tears manufactured by EzriCare and Delsam Pharma in January 2023.